First immune-evading cells created to treat type 1 diabetes

Scientists have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.6 million Americans with a cost of $14.4 billion annually. Using stem cell technology, researchers generated the first human insulin-producing pancreatic cell clusters able to evade the immune system. These ‘immune shielded’ cell clusters controlled blood glucose without immunosuppressive drugs once transplanted in the body.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *